UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+9.04%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$5.59B
AUM Growth
+$865M
(+18%)
Cap. Flow
+$450M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
66.42%
Holding
655
New
83
Increased
132
Reduced
97
Closed
122
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$800M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$386M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
+$274M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$189M |
| 5 |
VMW
VMware, Inc
VMW
|
+$172M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$230M |
| 2 |
PDCE
PDC Energy, Inc.
PDCE
|
+$221M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$219M |
| 4 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$146M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$141M |
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Healthcare | 28.93% |
| 3 | Real Estate | 5.18% |
| 4 | Financials | 4.45% |
| 5 | Consumer Discretionary | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Nektar Therapeutics
NKTR
$924M
| $820K | 0.01% |
+91,750
| New | +$820K |
|
327
Edgewise Therapeutics
EWTX
$1.57B
| $801K | 0.01% |
139,858
| – | – |
|
|
THRD
328
DELISTED
Third Harmonic Bio
THRD
| $799K | 0.01% |
+125,000
| New | +$799K |
|
329
Quanterix
QTRX
$210M
| $792K | 0.01% |
29,200
-4,800
| -14% | -$130K |
|
330
Crinetics Pharmaceuticals
CRNX
$3.44B
| $778K | 0.01% |
26,153
-30,000
| -53% | -$892K |
|
331
Intuit
INTU
$187B
| $766K | 0.01% |
+1,500
| New | +$766K |
|
332
BioAtla
BCAB
$41.9M
| $753K | 0.01% |
442,722
+40,000
| +10% | +$68K |
|
333
Rezolute
RZLT
$703M
| $736K | 0.01% |
557,307
+85,000
| +18% | +$112K |
|
334
Cabaletta Bio
CABA
$150M
| $736K | 0.01% |
48,332
-33,000
| -41% | -$502K |
|
|
FUSN
335
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $714K | 0.01% |
274,568
| – | – |
|
336
Zoom
ZM
$25.6B
| $699K | 0.01% |
10,000
-10,000
| -50% | -$699K |
|
|
SILK
337
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $697K | 0.01% |
46,528
-10,000
| -18% | -$150K |
|
338
Rhythm Pharmaceuticals
RYTM
$6.63B
| $688K | 0.01% |
+30,000
| New | +$688K |
|
339
Adobe
ADBE
$150B
| $655K | 0.01% |
1,284
+251
| +24% | +$128K |
|
|
ITOS
340
DELISTED
iTeos Therapeutics
ITOS
| $654K | 0.01% |
59,764
+8,000
| +15% | +$87.6K |
|
|
INZY
341
DELISTED
Inozyme Pharma
INZY
| $652K | 0.01% |
155,305
| – | – |
|
342
Editas Medicine
EDIT
$251M
| $642K | 0.01% |
82,369
| – | – |
|
343
Viking Therapeutics
VKTX
$2.84B
| $641K | 0.01% |
57,905
+16,000
| +38% | +$177K |
|
344
Amylyx Pharmaceuticals
AMLX
$937M
| $641K | 0.01% |
35,000
-4,000
| -10% | -$73.2K |
|
345
American Airlines Group
AAL
$8.42B
| $641K | 0.01% |
+50,000
| New | +$641K |
|
346
Charles River Laboratories
CRL
$7.97B
| $629K | 0.01% |
3,211
| – | – |
|
347
Tesla
TSLA
$1.12T
| $626K | 0.01% |
2,500
-1,000
| -29% | -$250K |
|
348
Esperion Therapeutics
ESPR
$512M
| $619K | 0.01% |
631,947
+335,000
| +113% | +$328K |
|
349
Highwoods Properties
HIW
$3.45B
| $618K | 0.01% |
30,000
-70,000
| -70% | -$1.44M |
|
350
Haleon
HLN
$43.6B
| $618K | 0.01% |
74,185
-180,000
| -71% | -$1.5M |
|